or Try an Advanced Search...

    Treatment Of Breast Cancer Stocks List

    Symbol Grade Name % Change
    GTHX A G1 Therapeutics, Inc. 0.00
    SLS C SELLAS Life Sciences Group, Inc. -1.32
    PBYI C Puma Biotechnology Inc 2.64
    VSTM D Verastem, Inc. 8.71
    HOLX D Hologic, Inc. 0.90
    CHRS D Coherus BioSciences, Inc. 4.45
    ICAD D icad inc. 2.39
    ZNTL D Zentalis Pharmaceuticals, Inc. 1.12
    CLDX D Celldex Therapeutics, Inc. 1.40
    ACHV F Achieve Life Sciences, Inc. 1.15
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
    Related Stock Lists: Breast Cancer Cancer Medicine Biotechnology Biopharmaceutical Solid Tumors Non Small Cell Lung Cancer Oncology Ovarian Cancer Prostate Cancer Small Cell Lung Cancer Advanced Breast Cancer Advanced Cancer Cancer Research Clinical Development Clinical Medicine Immunology Immunotherapy Lymphoma Oncolytics Biotech

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Breast Cancer stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.59
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.62
    SURI C Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 1.47
    SBIO C ALPS Medical Breakthroughs ETF 1.47
    XBI D SPDR S&P Biotech ETF 0.57
    View all Treatment Of Breast Cancer ETFs...
    Compare ETFs
    Compare BBC to SURI Compare BBC to XBI Compare CNCR to BBC

        Treatment Of Breast Cancer Stocks Recent News

        Date Stock Title
        Nov 21 PBYI PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer
        Nov 21 PBYI Puma commences Phase II trial of alisertib for breast cancer treatment
        Nov 20 PBYI Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 17 ICAD Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates
        Nov 16 ICAD iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Nov 16 SLS We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate
        Nov 15 HOLX Should You Retain Hologic Stock in Your Portfolio Now?
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
        Related Stock Lists: Breast Cancer Cancer Medicine Biopharmaceutical Clinical Medicine Oncology Epidermal Growth Factor Receptor Her2 Her2/Neu Ovarian Cancer Prostate Cancer Solid Tumors Advanced Cancer Antiestrogens Antineoplastic Drugs Biotechnology Clinical Development Drugs Estrogen Estrogen Receptor
        Treatment Of Breast Cancer

        Treatment of breast cancer depends on the type and stage of the cancer, as well as the patient's age, overall health, and personal preferences. Treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and/or immunotherapy.

        Browse All Tags